首页> 外文期刊>Breast care >A Clinicopathological Evaluation of Male Patients with Breast Cancer
【24h】

A Clinicopathological Evaluation of Male Patients with Breast Cancer

机译:男性乳腺癌男性患者的临床病理评价

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Although male breast cancer constitutes only 1% of all breast cancers, its incidence is increasing and it is becoming an important public health issue. The present study aims to present the clinicopathological characteristics of surgically treated male breast cancer patients from multiple centers. Patients and Methods: Twenty-one male patients operated on for breast cancer were retrospectively examined in terms of clinical presentation, pathological characteristics, TNM staging status, and type of surgical treatment. Results: The mean age of the 21 patients was 62.3 years (range 38-94), with the majority being in the range of 50-69 years (61.9%). The most frequent finding was breast mass (85.7%). Most patients underwent modified radical mastectomy (76.1%), and the most prevalent histological type was invasive ductal carcinoma (85.7%). The majority of patients had stage II or III disease, and estrogen receptors were positive in 18 (85.7%) of the patients. Conclusion: Since male breast cancer is a rare condition, it is challenging to conduct prospective randomized trials. Currently, there is a lack of comprehensive data on the diagnosis and management of this condition. Thus, further studies and the implementation of specific guidelines or protocols for this subgroup of patients will aid better management.
机译:背景:尽管男性乳腺癌仅占所有乳腺癌的1%,但其发病率正在上升,并且正在成为重要的公共卫生问题。本研究旨在从多个中心介绍经手术治疗的男性乳腺癌患者的临床病理特征。患者和方法:回顾性分析了21例接受乳腺癌手术的男性患者的临床表现,病理特征,TNM分期状态和手术治疗类型。结果:21例患者的平均年龄为62.3岁(范围38-94),大多数在50-69岁之间(61.9%)。最常见的发现是乳房肿块(85.7%)。大多数患者接受了改良的根治性乳房切除术(76.1%),最普遍的组织学类型是浸润性导管癌(85.7%)。大多数患者患有II或III期疾病,其中18名患者(85.7%)的雌激素受体阳性。结论:由于男性乳腺癌是一种罕见病,因此进行前瞻性随机试验具有挑战性。当前,缺乏关于该病的诊断和治疗的综合数据。因此,对该亚组患者的进一步研究和特定指南或方案的实施将有助于更好的管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号